Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TSER Genotype Guided Chemotherapy in Metastatic Gastric Cancer Patients: A Phase II Study in China

NCT02204306 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT02204306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02204306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TSER Genotype Guided Chemotherapy in Metastatic Gastric Cancer Patients: A Phase II Study in China
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
December 31, 2016
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic gastric cancer